98 related articles for article (PubMed ID: 3403324)
1. Elective lower neck irradiation: 5000 cGy/25 fractions versus 4050 cGy/15 fractions.
Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):439-40. PubMed ID: 3403324
[TBL] [Abstract][Full Text] [Related]
2. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
Chen AM; Vaughan A; Narayan S; Vijayakumar S
Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionation for head and neck cancer.
Parsons JT; Mendenhall WM; Cassisi NJ; Isaacs JH; Million RR
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):649-58. PubMed ID: 3350719
[TBL] [Abstract][Full Text] [Related]
4. Elective neck irradiation for squamous cell carcinoma of the head and neck: analysis of time-dose factors and causes of failure.
Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):741-6. PubMed ID: 3710858
[TBL] [Abstract][Full Text] [Related]
5. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
Perez CA; Pajak TF; Rubin P; Simpson JR; Mohiuddin M; Brady LW; Perez-Tamayo R; Rotman M
Cancer; 1987 Jun; 59(11):1874-81. PubMed ID: 3032394
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
7. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
8. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J; Hansen HS; Specht L; Overgaard M; Grau C; Andersen E; Bentzen J; Bastholt L; Hansen O; Johansen J; Andersen L; Evensen JF
Lancet; 2003 Sep; 362(9388):933-40. PubMed ID: 14511925
[TBL] [Abstract][Full Text] [Related]
9. Neutron therapy for locally advanced head and neck squamous cell carcinoma: optimum dose search.
Clubb B; el-Akkad S; el-Senoussi M; Schultz H; Calkins J; Rymel J; De Vol E
Strahlenther Onkol; 1990 Jan; 166(1):111-3. PubMed ID: 2405531
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
11. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
12. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
13. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
14. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
15. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
[TBL] [Abstract][Full Text] [Related]
16. Twice-daily fractionation schemes for advanced head and neck cancer.
Meoz RT; Fletcher GH; Peters LJ; Barkley HT; Thames HD
Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):831-6. PubMed ID: 6735767
[TBL] [Abstract][Full Text] [Related]
17. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
[TBL] [Abstract][Full Text] [Related]
18. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck.
Grénman R; Carey TE; McClatchey KD; Wagner JG; Pekkola-Heino K; Schwartz DR; Wolf GT; Lacivita LP; Ho L; Baker SR
Cancer; 1991 Jun; 67(11):2741-7. PubMed ID: 2025837
[TBL] [Abstract][Full Text] [Related]
19. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
20. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm.
Arnold SM; Regine WF; Ahmed MM; Valentino J; Spring P; Kudrimoti M; Kenady D; Desimone P; Mohiuddin M
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1411-7. PubMed ID: 15050317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
